1-3 of 3
Klaus M. Debatin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Favourable Treatment Outcome in Childhood AML Is Determined by Intact Apoptosis Signalling in Myeloid Leukaemia Cells.

Lüder H. Meyer, MD, Manon Dammé, Sarah M. Eckhoff, MD, Ursula Creutzig, MD, Dirk Reinhardt, MD, Leonid Karawajew, PhD, Wolf D. Ludwig, MD, Karsten Stahnke, MD, Klaus M. Debatin, MD
Journal: Blood
Blood (2007) 110 (11): 2842.
https://doi.org/10.1182/blood.V110.11.2842.2842
Published: 2007
Journal Articles

Time to Leukaemia (TTL) Assessed in NOD/SCID Mice Transplanted with Primary ALL Leukaemia Cells Determines Early Relapse in Patients and Is Identified by a Specific Gene Signature.

Lüder H. Meyer, MD, Sarah M. Eckhoff, MD, Manon Dammé, Martin Zimmermann, PhD, André Schrauder, MD, Georgia Lahr, PhD, Karsten Stahnke, MD, Martin Schrappe, MD, Klaus M. Debatin, MD
Journal: Blood
Blood (2007) 110 (11): 726.
https://doi.org/10.1182/blood.V110.11.726.726
Published: 2007
Journal Articles

Cytochrome C Related Caspase Activation Determines Treatment Response in Childhood B- Precursor ALL.

Lueder H. Meyer, Leonid Karawajew, Martin Schrappe, Wolf D. Ludwig, Klaus M. Debatin, Karsten Stahnke
Journal: Blood
Blood (2004) 104 (11): 990.
https://doi.org/10.1182/blood.V104.11.990.990
Published: 2004